MAPT and Alzheimer disease: In the current study, we found a significant correlation between decreased CDK5 level and increased P-tau 396 level in the CSF from AD-OSA patients (Figure 4), indicating that OSA may activate CDK5 and was primarily associated with enhanced tau phosphorylation at the site of Ser396.